Development of second generation amidinohydrazones, thio- and semicarbazones as Trypanosoma cruzi-inhibitors bearing benzofuroxan and benzimidazole 1,3-dioxide core scaffolds
(3 BROMOPHENYL)ETHYLKETONE THIOSEMICARBAZONE;
5 (2 ACETYLPHENYLOXYMETHYL) 2,2 DIMETHYL 2H BENZIMIDAZOLE 1,3 DI N OXIDE;
5 (2 ACETYLPHENYLOXYMETHYL)BENZO[1,2 C] 1,2,5 OXADIAZOLE N OXIDE;
5 (2 AMIDINOHYDRAZONOPHENYLOXYMETHYL)BENZO[1,2 C] 1,2,5 OXADIAZOLE N OXIDE;
5 (2 FORMYLPHENYLOXYMETHYL)BENZO[1,2 C] 1,2,5 OXADIAZOLE N OXIDE;
5 (2 METHYLAMIDINOHYDRAZONOPHENYLOXYMETHYL)BENZO[1,2 C] 1,2,5 OXADIAZOLE N OXIDE;
5 (2 SEMICARBAZONOPHENYLOXYMETHYL)BENZO[1,2 C] 1,2,5 OXADIAZOLE N OXIDE;
5 (2 THIOSEMICARBAZONOPHENYLOXYMETHYL)BENZO[1,2 C] 1,2,5 OXADIAZOLE N OXIDE;
5 (3 AMIDINOHYDRAZONOPHENYLOXYMETHYL)BENZO[1,2 C] 1,2,5 OXADIAZOLE N OXIDE;
5 (3 FORMYLPHENYLOXYMETHYL) 2,2 DIMETHYL 2H BENZIMIDAZOLE 1,3 DI N OXIDE;
5 (3 FORMYLPHENYLOXYMETHYL)BENZO[1,2 C] 1,2,5 OXADIAZOLE N OXIDE;
5 (3 THIOSEMICARBAZONOPHENYLOXYMETHYL)BENZO[1,2 C] 1,2,5 OXADIAZOLE N OXIDE;
5 (4 FORMYLPHENYLOXYMETHYL) 2,2 DIMETHYL 2H BENZIMIDAZOLE 1,3 DI N OXIDE;
5 (4 THIOSEMICARBAZONOPHENYLOXYMETHYL) 2,2 DIMETHYL 2H BENZIMIDAZOLE 1,3 DI N OXIDE;
5 [2 (N4 ALLYLTHIOSEMICARBAZONO)PHENYLOXYMETHYL]BENZO[1,2 C] 1,2,5 OXADIAZOLE N OXIDE;
5 [2 (N4 PHENYLTHIOSEMICARBAZONO)PHENYLOXYMETHYL]BENZO[1,2 C] 1,2,5 OXADIAZOLE N OXIDE;
5 [3 (N4 ALLYLTHIOSEMICARBAZONO)PHENYLOXYMETHYL]BENZO[1,2 C] 1,2,5 OXADIAZOLE N OXIDE;
5 [4 (N4 ALLYLTHIOSEMICARBAZONO)PHENYLOXYMETHYL] 2,2 DIMETHYL 2H BENZIMIDAZOLE 1,3 DI N OXIDE;
5 [4 (N4 ALLYLTHIOSEMICARBAZONO)PHENYLOXYMETHYL]BENZO[1,2 C] 1,2,5 OXADIAZOLE N OXIDE;
5 [4 (N4 PHENYLTHIOSEMICARBAZONO)PHENYLOXYMETHYL] 2,2 DIMETHYL 2H BENZIMIDAZOLE 1,3 DI N OXIDE;
5 [4 (N4 PHENYLTHIOSEMICARBAZONO)PHENYLOXYMETHYL]BENZO[1,2 C] 1,2,5 OXADIAZOLE N OXIDE;
AMIDINOHYDRAZONE;
ANTITRYPANOSOMAL AGENT;
BENZIMIDAZOLE 1,3 DIOXIDE DERIVATIVE;
BENZNIDAZOLE;
BENZOFUROXAN DERIVATIVE;
NIFURTIMOX;
SEMICARBAZONE DERIVATIVE;
THIOSEMICARBAZONE DERIVATIVE;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
ANIMAL CELL;
ANTIPROTOZOAL ACTIVITY;
ARTICLE;
CONTROLLED STUDY;
DRUG CYTOTOXICITY;
DRUG PROTEIN BINDING;
DRUG SELECTIVITY;
DRUG STRUCTURE;
DRUG SYNTHESIS;
ENZYME INHIBITION;
ERYTHROCYTE;
HUMAN;
HUMAN CELL;
IN VITRO STUDY;
MACROPHAGE;
MOLECULAR DOCKING;
MOUSE;
NONHUMAN;
PRIORITY JOURNAL;
TRYPANOSOMA CRUZI;
Chagas Disease; Special Programme for Research and Training in Tropical Diseases (TDR), World Health Organization, Geneva, http://www.who.int/tdr/ diseases/chagas/direction.htm
L. Otero M. Vieites L. Boiani A. Denicola C. Rigol L. Opazo C. Olea-Azar J. D. Maya A. Morello R. L. Krauth-Siegel O. E. Piro E. Castellano M. González D. Gambino H. Cerecetto J. Med. Chem. 2006 49 3322 3331
M. Vieites L. Otero D. Santos J. Toloza R. Figueroa E. Norambuena C. Olea-Azar G. Aguirre H. Cerecetto M. González A. Morello J. D. Maya B. Garat D. Gambino J. Inorg. Biochem. 2008 102 1033 1043
M. Vieites L. Otero D. Santos C. Olea-Azar E. Norambuena G. Aguirre H. Cerecetto M. González U. Kemmerling A. Morello J. D. Maya D. Gambino J. Inorg. Biochem. 2009 103 411 418
W. Porcal P. Hernández M. Boiani G. Aguirre L. Boiani A. Chidichimo J. J. Cazzulo N. E. Campillo J. A. Paez A. Castro R. L. Krauth-Siegel C. Davies M. A. Basombrío M. González H. Cerecetto J. Med. Chem. 2007 50 6004 6015
W. Porcal P. Hernandez L. Boiani M. Boiani A. Ferreira A. Chidichimo J. J. Cazzulo C. Olea-Azar M. González H. Cerecetto Bioorg. Med. Chem. 2008 16 6995 7004
N. Fujii J. P. Mallari E. J. Hansell Z. Mackey P. Doyle Y. M. Zhou J. Gut P. J. Rosenthal J. H. McKerrow R. Kiplin Guy Bioorg. Med. Chem. Lett. 2005 15 121 123
C. Olea-Azar C. Rigol F. Mendizábal H. Cerecetto R. Di Maio M. González W. Porcal A. Morello Y. Repetto J. D. Maya Lett. Drug Des. Discovery 2005 2 294 301
M. Boiani L. Boiani A. Denicola S. Torres de Ortiz E. Serna N. Vera de Bilbao L. Sanabria G. Yaluff H. Nakayama A. Rojas de Arias C. Vega M. Rolón A. Gómez-Barrio H. Cerecetto M. Gonzalez J. Med. Chem. 2006 49 3215 3224
L. Boiani C. Davies C. Arredondo W. Porcal A. Merlino A. Gerpe M. Boiani J. P. Pacheco M. A. Basombrío H. Cerecetto M. González Eur. J. Med. Chem. 2008 43 2229 2237
L. Boiani A. Gerpe V. J. Arán S. Torres de Ortiz E. Serna N. Vera de Bilbao L. Sanabria G. Yaluff H. Nakayama A. Rojas de Arias J. D. Maya A. Morello H. Cerecetto M. González Eur. J. Med. Chem. 2009 44 1034 1040
J. M. Pereira R. P. Severino P. C. Vieira J. B. Fernandes M. F. G. F. da Silva A. Zottis A. D. Andricopulo G. Oliva A. G. Corrêa Bioorg. Med. Chem. 2008 16 8889 8895
R. F. Freitas I. M. Prokopczyk A. Zottis G. Oliva A. D. Andricopulo M. T. S. Trevisan W. Vilegas M. G. V. Silva C. A. Montanari Bioorg. Med. Chem. 2009 17 2476 2482
N. Fujii J. P. Mallari E. J. Hansell Z. Mackey P. Doyle Y. M. Zhou J. Gut P. J. Rosenthal J. H. McKerrow R. Kiplin Guy Bioorg. Med. Chem. Lett. 2005 15 121 123
A. C. Lima Leite R. Souza de Lima D. R.de M. Moreira M. V.de O. Cardoso A. C. Gouveia de Brito L. M. Farias dos Santos M. Zaldini Hernandes A. Costa Kiperstok R. Santana de Lima M. B. P. Soares Bioorg. Med. Chem. 2006 14 3749 3757
K. B. Lipkowitz and D. B. Boyd, VCH Publishers, New York, pp. 1-73
R. Judson, Genetic algorithms and their use in chemistry, in Reviews in Computational Chemistry, ed., K. B. Lipkowitz, and, D. B. Boyd,, vol. 10, VCH Publishers, New York, 1997, pp. 1-73
D. C. Greenbaum Z. Mackey E. Hansell P. Doyle J. Gut C. R. Caffrey J. Lehrman P. J. Rosenthal J. H. McKerrow K. Chibale J. Med. Chem. 2004 47 3212 3219
Compounds properties calculation. Polar surface area (TPSA), miLog P, and violations of Lipinski's rule of five, were calculated using Molinspiration online property calculation toolkit: http://www.molinspiration.com/cgi-bin/ properties